Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals’ (AMPH) Narrative?
In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide…
Browsing Tag